ArticleFrontiers in oncology2020

Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas.

Andrew J Shih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.